GATA3 as a putative marker of breast cancer metastasis-A retrospective immunohistochemical study.
Breast J
; 24(2): 184-188, 2018 03.
Article
em En
| MEDLINE
| ID: mdl-28703335
ABSTRACT
Diagnostic verification of breast cancer metastasis with histopathology and imaging analysis is essential to determine tumor staging. The aim of this study was to validate the utility of GATA3 immunohistochemistry as a diagnostic marker for breast cancer metastases and metastases of unknown primary origin. Retrospective immunohistochemical analysis of GATA3 expression in 164 breast cancer metastases diagnosed between 2004 and 2014 showed a striking difference between mammaglobin and GATA3 expression (51.2% vs 94% positivity). These findings highlight GATA3 as a more reliable and sensitive diagnostic marker for breast cancer metastases and possibly metastatic tumors of unknown origin than mammaglobin.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Biomarcadores Tumorais
/
Fator de Transcrição GATA3
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article